← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

M

$ Value

$0

Shares

17,000

Price

$0

Filed

Sep 10

Insider

Name

Ramasastry Saira

Title

CIK

0001547959

Roles

Director

Transaction Details

Transaction Date

2025-09-08

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,000

Footnotes

The weighted average sale price for the transaction reported was $77.042178, and the range of prices were between $76.835 and $77.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The stock option is fully vested.

Filing Info

Accession No.

0001415889-25-024128

Form Type

4

Issuer CIK

0001759425

Ramasastry Saira's History

Date Ticker Type Value
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-23 DAWN D
2026-04-15 MIRM M $47K
2026-04-15 MIRM $194K

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$101K 2026-01-28
Ramasastry Saira $398K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-02-02
Radovich Peter
PRESIDENT AND COO
$574K 2026-02-02
Quan Joanne
CHIEF MEDICAL OFFICER
2026-01-28
Howe Jolanda
SVP, GLOBAL CONTROLLER
$181K 2026-02-02